1. Real-Life Effectivity of Dose Intensity Reduction of First-Line mFOLFIRI-Based Treatment of Metastatic Colorectal Cancers: Sometimes Less Is More
   Balázs Pécsi et al, 2023, Current Oncology CrossRef
2. NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors
   Michael Cecchini et al, 2023, Cancer Research Communications CrossRef
3. Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors
   Thomas J. Semrad et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef